These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 38761204

  • 1. [Radiologically guided interventional therapies for the treatment of neuroendocrine tumors].
    Radosa CG, Nebelung H, Schön F, Hoffmann RT.
    Radiologie (Heidelb); 2024 Jul; 64(7):575-581. PubMed ID: 38761204
    [Abstract] [Full Text] [Related]

  • 2. Transarterial Chemoembolization vs Radioembolization for Neuroendocrine Liver Metastases: A Multi-Institutional Analysis.
    Egger ME, Armstrong E, Martin RC, Scoggins CR, Philips P, Shah M, Konda B, Dillhoff M, Pawlik TM, Cloyd JM.
    J Am Coll Surg; 2020 Apr; 230(4):363-370. PubMed ID: 32032719
    [Abstract] [Full Text] [Related]

  • 3. Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors.
    Fiore F, Del Prete M, Franco R, Marotta V, Ramundo V, Marciello F, Di Sarno A, Carratù AC, de Luca di Roseto C, Colao A, Faggiano A.
    Endocrine; 2014 Sep; 47(1):177-82. PubMed ID: 24385266
    [Abstract] [Full Text] [Related]

  • 4. Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference.
    Kennedy A, Bester L, Salem R, Sharma RA, Parks RW, Ruszniewski P, NET-Liver-Metastases Consensus Conference.
    HPB (Oxford); 2015 Jan; 17(1):29-37. PubMed ID: 25186181
    [Abstract] [Full Text] [Related]

  • 5. GEP-NETS update: Interventional radiology: role in the treatment of liver metastases from GEP-NETs.
    de Baere T, Deschamps F, Tselikas L, Ducreux M, Planchard D, Pearson E, Berdelou A, Leboulleux S, Elias D, Baudin E.
    Eur J Endocrinol; 2015 Apr; 172(4):R151-66. PubMed ID: 25385817
    [Abstract] [Full Text] [Related]

  • 6. Hepatic intra-arterial therapies in metastatic neuroendocrine tumors: lessons from clinical practice.
    Grozinsky-Glasberg S, Kaltsas G, Kaltsatou M, Lev-Cohain N, Klimov A, Vergadis V, Uri I, Bloom AI, Gross DJ.
    Endocrine; 2018 Jun; 60(3):499-509. PubMed ID: 29383678
    [Abstract] [Full Text] [Related]

  • 7. Liver transarterial embolizations in metastatic neuroendocrine tumors.
    de Mestier L, Zappa M, Hentic O, Vilgrain V, Ruszniewski P.
    Rev Endocr Metab Disord; 2017 Dec; 18(4):459-471. PubMed ID: 28975561
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival.
    Chen JX, Rose S, White SB, El-Haddad G, Fidelman N, Yarmohammadi H, Hwang W, Sze DY, Kothary N, Stashek K, Wileyto EP, Salem R, Metz DC, Soulen MC.
    Cardiovasc Intervent Radiol; 2017 Jan; 40(1):69-80. PubMed ID: 27738818
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transarterial (chemo)embolisation versus systemic chemotherapy for colorectal cancer liver metastases.
    Swierz MJ, Storman D, Mitus JW, Hetnal M, Kukielka A, Szlauer-Stefanska A, Pedziwiatr M, Wolff R, Kleijnen J, Bala MM.
    Cochrane Database Syst Rev; 2024 Aug 09; 8(8):CD012757. PubMed ID: 39119869
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Liver-Directed Therapies for Neuroendocrine Neoplasms.
    Clift AK, Frilling A.
    Curr Oncol Rep; 2021 Mar 15; 23(4):44. PubMed ID: 33721122
    [Abstract] [Full Text] [Related]

  • 16. Transarterial liver-directed therapies of neuroendocrine hepatic metastases.
    Nazario J, Gupta S.
    Semin Oncol; 2010 Apr 15; 37(2):118-26. PubMed ID: 20494704
    [Abstract] [Full Text] [Related]

  • 17. Interventional Oncology: Optimizing Transarterial Therapies for the Treatment of Hepatic Malignancy.
    Kouri BE.
    Tech Vasc Interv Radiol; 2018 Dec 15; 21(4):205-222. PubMed ID: 30545499
    [Abstract] [Full Text] [Related]

  • 18. Long-Term Toxicity after Transarterial Radioembolization with Yttrium-90 Using Resin Microspheres for Neuroendocrine Tumor Liver Metastases.
    Tomozawa Y, Jahangiri Y, Pathak P, Kolbeck KJ, Schenning RC, Kaufman JA, Farsad K.
    J Vasc Interv Radiol; 2018 Jun 15; 29(6):858-865. PubMed ID: 29724520
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Outcomes After Transarterial Embolization of Neuroendocrine Tumor Liver Metastases Using Spherical Particles of Different Sizes.
    Zener R, Yoon H, Ziv E, Covey A, Brown KT, Sofocleous CT, Thornton RH, Boas FE.
    Cardiovasc Intervent Radiol; 2019 Apr 15; 42(4):569-576. PubMed ID: 30627774
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.